Symbols / DOC Stock $16.43 +0.12% Healthpeak Properties, Inc.

Real Estate • REIT - Healthcare Facilities • United States • NYQ
DOC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Real Estate
Industry REIT - Healthcare Facilities
CEO Mr. Scott M. Brinker
Exch · Country NYQ · United States
Market Cap 11.42B
Enterprise Value 21.89B
Income 70.51M
Sales 2.82B
FCF (ttm) 1.16B
Book/sh 10.79
Cash/sh 0.68
Employees 411
Insider 10d —
IPO May 23, 1985
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 12.20%
P/E 164.30
Forward P/E 121.70
PEG 4.32
P/S 4.05
P/B 1.52
P/C —
EV/EBITDA 14.07
EV/Sales 7.76
Quick Ratio 0.67
Current Ratio 1.22
Debt/Eq 122.18
LT Debt/Eq —
EPS (ttm) 0.10
EPS next Y 0.14
EPS Growth 24.48%
Revenue Growth 3.10%
EPS Gr Q/Q 24.06%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-02
ROA 1.66%
ROE 1.16%
ROIC —
Gross Margin 59.97%
Oper. Margin 20.07%
Profit Margin 2.53%
Shs Outstand 695.26M
Shs Float 692.31M
Insider Own 0.29%
Instit Own 97.98%
Short Float 5.97%
Short Ratio 3.68
Short Interest 32.01M
52W High 19.68
vs 52W High -16.51%
52W Low 15.71
vs 52W Low 4.58%
Beta 1.08
Impl. Vol. 42.04%
Rel Volume 0.93
Avg Volume 8.91M
Volume 8.26M
Target (mean) $19.64
Tgt Median $19.00
Tgt Low $16.00
Tgt High $29.00
# Analysts 18
Recom Buy
Prev Close $16.41
Price $16.43
Change 0.12%
About

Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical – 530 properties; (ii) Lab – 139 properties; (iii) CCRC – 15 properties; and (iv) Other non-reportable – 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$19.64
Mean price target
2. Current target
$16.43
Latest analyst target
3. DCF / Fair value
$30.10
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.43
Low
$16.00
High
$29.00
Mean
$19.64

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 init UBS — → Neutral $17
2026-04-06 main Baird Outperform → Outperform $19
2026-04-01 main Citigroup Neutral → Neutral $18
2026-02-05 down Argus Research Buy → Hold —
2026-02-04 main Evercore ISI Group Outperform → Outperform $19
2026-02-02 main Wells Fargo Equal-Weight → Equal-Weight $18
2026-01-09 init Goldman Sachs — → Neutral $17
2025-12-16 down Jefferies Buy → Hold $17
2025-12-15 main Evercore ISI Group Outperform → Outperform $21
2025-11-25 main Wells Fargo Equal-Weight → Equal-Weight $19
2025-11-12 main Baird Outperform → Outperform $20
2025-10-01 init Cantor Fitzgerald — → Neutral $20
2025-09-15 up Raymond James Market Perform → Outperform $20
2025-08-27 main Wells Fargo Equal-Weight → Equal-Weight $18
2025-08-22 main Morgan Stanley Overweight → Overweight $21
2025-08-20 down Deutsche Bank Buy → Hold $18
2025-07-30 main Baird Outperform → Outperform $21
2025-07-29 down Scotiabank Sector Outperform → Sector Perform $19
2025-06-02 main Wells Fargo Equal-Weight → Equal-Weight $20
2025-05-12 main Scotiabank Sector Outperform → Sector Outperform $21
News
RSS: Latest DOC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-06 THOMAS JOHN T Director — 23,739 $0.00 $0
2026-01-28 ALONSO LISA A Officer — 4,284 $0.00 $0
2025-11-28 BRINKER SCOTT M Chief Executive Officer — 1,689 $14.80 $24,995
2025-11-28 JOHNSTON SHAWN G Officer — 1,689 $14.80 $24,995
2025-11-28 ALONSO LISA A Officer — 338 $14.80 $5,002
2025-11-28 MABRY ADAM G Chief Investment Officer — 844 $14.80 $12,490
2025-11-28 PATADIA ANKIT B Officer and Treasurer — 1,689 $14.80 $24,995
2025-11-28 MOSES KELVIN O Chief Financial Officer — 810 $14.80 $11,987
2025-11-28 THOMAS JOHN T Director — 1,448 $14.80 $21,428
2025-08-06 THOMAS JOHN T Director — 1,450 $17.06 $24,730
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,822.51
+4.52%
2,700.45
+23.82%
2,181.00
+5.81%
2,061.18
Operating Revenue
2,822.51
+4.52%
2,700.45
+23.82%
2,181.00
+5.81%
2,061.18
Cost Of Revenue
1,129.10
+5.05%
1,074.86
+19.16%
902.06
+4.53%
862.99
Reconciled Cost Of Revenue
1,165.85
+5.45%
1,105.62
+19.16%
927.85
+7.52%
862.99
Gross Profit
1,693.41
+4.17%
1,625.59
+27.10%
1,278.94
+6.74%
1,198.19
Operating Expense
1,149.28
-0.44%
1,154.37
+36.61%
845.03
+0.41%
841.60
Selling General And Administration
90.42
-6.94%
97.16
+2.13%
95.13
-27.40%
131.03
General And Administrative Expense
90.42
-6.94%
97.16
+2.13%
95.13
-27.40%
131.03
Other Gand A
90.42
-6.94%
97.16
+2.13%
95.13
-27.40%
131.03
Total Expenses
2,278.38
+2.20%
2,229.23
+27.60%
1,747.09
+2.49%
1,704.59
Operating Income
544.13
+15.47%
471.22
+8.60%
433.91
+21.68%
356.58
EBITDA
1,648.34
+2.33%
1,610.80
+27.32%
1,265.17
-9.02%
1,390.64
Normalized EBITDA
1,603.48
+0.99%
1,587.77
+33.36%
1,190.62
-14.55%
1,393.42
Reconciled Depreciation
1,022.12
-0.42%
1,026.45
+41.75%
724.11
+1.91%
710.57
EBIT
589.47
+6.48%
553.60
+7.44%
515.27
-24.23%
680.07
Total Unusual Items
44.86
+94.78%
23.03
-69.10%
74.55
+2782.58%
-2.78
Total Unusual Items Excluding Goodwill
44.86
+94.78%
23.03
-69.10%
74.55
+2782.58%
-2.78
Special Income Charges
-24.63
+84.18%
-155.66
-1206.56%
-11.91
-0.48%
-11.86
Other Special Charges
—
—
—
—
Restructuring And Mergern Acquisition
25.52
-80.77%
132.69
+657.55%
17.52
+260.91%
4.85
Write Off
-0.89
-103.89%
22.98
+510.25%
-5.60
-179.97%
7.00
Net Income
71.35
-70.66%
243.14
-20.54%
306.01
-38.85%
500.45
Pretax Income
284.29
+4.07%
273.17
-13.26%
314.94
-37.90%
507.13
Net Non Operating Interest Income Expense
-305.18
-8.83%
-280.43
-39.98%
-200.33
-15.84%
-172.94
Interest Expense Non Operating
305.18
+8.83%
280.43
+39.98%
200.33
+15.84%
172.94
Net Interest Income
-305.18
-8.83%
-280.43
-39.98%
-200.33
-15.84%
-172.94
Interest Expense
305.18
+8.83%
280.43
+39.98%
200.33
+15.84%
172.94
Other Income Expense
45.34
-44.96%
82.38
+1.25%
81.36
-74.85%
323.49
Other Non Operating Income Expenses
0.48
-99.19%
59.34
+771.70%
6.81
-97.91%
326.27
Gain On Sale Of Security
69.49
-61.11%
178.69
+106.67%
86.46
+852.45%
9.08
Tax Provision
9.28
+113.40%
4.35
+145.23%
-9.62
-117.33%
-4.42
Tax Rate For Calcs
0.00
+105.06%
0.00
-92.42%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
1.46
+299.39%
0.37
-97.66%
15.66
+2782.58%
-0.58
Net Income Including Noncontrolling Interests
101.03
-62.21%
267.30
-20.15%
334.76
-35.18%
516.42
Net Income From Continuing Operation Net Minority Interest
71.35
-70.66%
243.14
-20.54%
306.01
-38.50%
497.56
Net Income From Continuing And Discontinued Operation
71.35
-70.66%
243.14
-20.54%
306.01
-38.85%
500.45
Net Income Continuous Operations
101.03
-62.21%
267.30
-20.15%
334.76
-34.81%
513.54
Net Income Discontinuous Operations
—
0.00
0.00
-100.00%
2.88
Minority Interests
-29.68
-22.84%
-24.16
+15.96%
-28.75
-79.96%
-15.97
Normalized Income
27.95
-87.32%
220.48
-10.78%
247.12
-50.55%
499.76
Net Income Common Stockholders
70.51
-70.91%
242.38
-20.34%
304.28
-38.87%
497.79
Otherunder Preferred Stock Dividend
0.83
+10.03%
0.76
-56.06%
1.73
-35.08%
2.66
Diluted EPS
0.10
-72.22%
0.36
-35.71%
0.56
-39.13%
0.92
Basic EPS
0.10
-72.22%
0.36
-35.71%
0.56
-39.13%
0.92
Basic Average Shares
696.03
+3.01%
675.68
+23.52%
547.01
+1.52%
538.81
Diluted Average Shares
696.04
+2.93%
676.23
+23.56%
547.27
+1.51%
539.15
Diluted NI Availto Com Stockholders
70.51
-70.92%
242.49
-20.31%
304.28
-38.87%
497.79
Average Dilution Earnings
0.00
-100.00%
0.11
0.00
—
Depreciation Amortization Depletion Income Statement
1,058.87
+0.16%
1,057.20
+40.98%
749.90
+5.54%
710.57
Depreciation And Amortization In Income Statement
1,058.87
+0.16%
1,057.20
+40.98%
749.90
+5.54%
710.57
Earnings From Equity Interest Net Of Tax
-173.98
-11384.09%
-1.51
-114.85%
10.20
+414.06%
1.99
Line Item Trend 2023-12-31
Total Assets
15,698.85
Current Assets
561.28
Cash Cash Equivalents And Short Term Investments
117.64
Cash And Cash Equivalents
117.64
Receivables
274.27
Accounts Receivable
55.82
Gross Accounts Receivable
58.10
Allowance For Doubtful Accounts Receivable
-2.28
Loans Receivable
218.45
Restricted Cash
51.39
Assets Held For Sale Current
117.99
Total Non Current Assets
15,137.57
Net PPE
240.16
Gross PPE
240.16
Other Properties
240.16
Goodwill And Other Intangible Assets
314.16
Goodwill
—
Other Intangible Assets
314.16
Investments And Advances
782.85
Long Term Equity Investment
782.85
Other Investments
—
Non Current Deferred Assets
—
Non Current Deferred Taxes Assets
—
Other Non Current Assets
772.04
Total Liabilities Net Minority Interest
8,773.98
Current Liabilities
1,377.92
Payables And Accrued Expenses
657.20
Payables
240.26
Accounts Payable
240.26
Current Accrued Expenses
416.94
Current Debt And Capital Lease Obligation
720.00
Current Debt
720.00
Other Current Liabilities
0.73
Total Non Current Liabilities Net Minority Interest
7,396.06
Long Term Debt And Capital Lease Obligation
6,363.04
Long Term Debt
6,156.30
Long Term Capital Lease Obligation
206.74
Non Current Deferred Liabilities
905.63
Non Current Deferred Revenue
905.63
Other Non Current Liabilities
127.38
Stockholders Equity
6,350.45
Common Stock Equity
6,350.45
Capital Stock
547.16
Common Stock
547.16
Share Issued
547.16
Ordinary Shares Number
547.16
Treasury Shares Number
0.00
Additional Paid In Capital
10,405.78
Retained Earnings
—
Gains Losses Not Affecting Retained Earnings
19.37
Minority Interest
574.42
Other Equity Adjustments
19.37
Total Equity Gross Minority Interest
6,924.87
Total Capitalization
12,506.75
Working Capital
-816.65
Invested Capital
13,226.75
Total Debt
7,083.04
Net Debt
6,758.66
Capital Lease Obligations
206.74
Net Tangible Assets
6,036.29
Tangible Book Value
6,036.29
Commercial Paper
720.00
Interest Payable
59.49
Investment Properties
13,028.36
Investmentsin Joint Venturesat Cost
782.85
Line Of Credit
720.00
Other Equity Interest
-4,621.86
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,251.96
+16.95%
1,070.50
+11.95%
956.24
+6.22%
900.26
Cash Flow From Continuing Operating Activities
1,251.96
+16.95%
1,070.50
+11.95%
956.24
+6.22%
900.26
Net Income From Continuing Operations
101.03
-62.21%
267.30
-20.15%
334.76
-35.18%
516.42
Depreciation Amortization Depletion
1,022.12
-0.42%
1,026.45
+41.75%
724.11
+1.91%
710.57
Depreciation
1,058.87
+0.16%
1,057.20
+40.98%
749.90
—
Amortization Cash Flow
-36.75
-19.48%
-30.75
-19.25%
-25.79
—
Depreciation And Amortization
1,022.12
-0.42%
1,026.45
+41.75%
724.11
+1.91%
710.57
Amortization Of Intangibles
-36.75
-19.48%
-30.75
-19.25%
-25.79
—
Other Non Cash Items
-115.91
-47.93%
-78.35
+6.56%
-83.85
+34.18%
-127.39
Stock Based Compensation
14.41
-54.64%
31.77
+119.38%
14.48
-45.27%
26.46
Asset Impairment Charge
-0.89
-103.89%
22.98
+510.25%
-5.60
-179.97%
7.00
Deferred Tax
3.85
+327.11%
-1.69
+88.41%
-14.61
-143.38%
-6.00
Deferred Income Tax
3.85
+327.11%
-1.69
+88.41%
-14.61
-143.38%
-6.00
Operating Gains Losses
104.50
+141.02%
-254.73
-162.87%
-96.90
+72.04%
-346.60
Gain Loss On Investment Securities
-69.49
+61.11%
-178.69
-106.67%
-86.46
-161.10%
-33.12
Change In Working Capital
105.75
+136.17%
44.77
-46.02%
82.94
-30.22%
118.86
Change In Receivables
-16.27
+60.19%
-40.86
-89.46%
-21.57
-23.71%
-17.43
Changes In Account Receivables
-16.27
+60.19%
-40.86
-89.46%
-21.57
-23.71%
-17.43
Change In Payables And Accrued Expense
-25.29
+11.71%
-28.64
+29.69%
-40.73
-129.89%
136.29
Change In Payable
-25.29
+11.71%
-28.64
+29.69%
-40.73
-129.89%
136.29
Change In Account Payable
-25.29
+11.71%
-28.64
+29.69%
-40.73
-129.89%
136.29
Change In Other Working Capital
147.30
+28.90%
114.28
-21.32%
145.24
—
Investing Cash Flow
-1,034.67
-809.21%
-113.80
+80.27%
-576.75
+34.19%
-876.34
Cash Flow From Continuing Investing Activities
-1,034.67
-809.21%
-113.80
+80.27%
-576.75
+34.19%
-876.34
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
0.00
Net Business Purchase And Sale
-86.77
+24.65%
-115.16
-30.28%
-88.39
-184.31%
104.84
Purchase Of Business
-86.77
+63.97%
-240.82
-172.45%
-88.39
-318.06%
-21.14
Gain Loss On Sale Of Business
0.00
+100.00%
-77.55
-33040.17%
-0.23
+99.92%
-311.44
Net Other Investing Changes
-63.77
+3.11%
-65.82
-168.28%
96.40
+5399.56%
-1.82
Financing Cash Flow
136.11
+114.46%
-941.42
-179.10%
-337.30
-189.45%
-116.53
Cash Flow From Continuing Financing Activities
136.11
+114.46%
-941.42
-179.10%
-337.30
-189.45%
-116.53
Net Issuance Payments Of Debt
1,108.68
+623.59%
153.22
-59.47%
378.08
+16.48%
324.58
Issuance Of Debt
13,108.33
+191.86%
4,491.25
-59.50%
11,088.48
-32.31%
16,382.15
Repayment Of Debt
-11,999.65
-176.62%
-4,338.03
+59.50%
-10,710.40
+33.30%
-16,057.57
Long Term Debt Issuance
13,108.33
+191.86%
4,491.25
-59.50%
11,088.48
-32.31%
16,382.15
Long Term Debt Payments
-11,999.65
-176.62%
-4,338.03
+59.50%
-10,710.40
+33.30%
-16,057.57
Net Long Term Debt Issuance
1,108.68
+623.59%
153.22
-59.47%
378.08
+16.48%
324.58
Short Term Debt Issuance
—
—
10,344.70
-34.87%
15,882.15
Short Term Debt Payments
—
—
-10,620.31
+33.84%
-16,052.52
Net Short Term Debt Issuance
—
—
-275.61
-61.77%
-170.37
Net Common Stock Issuance
-96.00
+49.57%
-190.37
-2947.92%
-6.25
-102.60%
240.26
Common Stock Payments
-97.14
+49.06%
-190.69
-2822.90%
-6.52
+90.38%
-67.84
Common Stock Dividend Paid
-849.10
-6.83%
-794.78
-20.97%
-657.02
-1.38%
-648.05
Cash Dividends Paid
-849.10
-6.83%
-794.78
-20.97%
-657.02
-1.38%
-648.05
Repurchase Of Capital Stock
-97.14
+49.06%
-190.69
-2822.90%
-6.52
+90.38%
-67.84
Net Other Financing Charges
-27.47
+74.91%
-109.48
-110.07%
-52.12
-56.36%
-33.33
Changes In Cash
353.40
+2212.50%
15.28
-63.78%
42.19
+145.55%
-92.61
Effect Of Exchange Rate Changes
—
—
—
0.00
Beginning Cash Position
184.31
+9.04%
169.02
+33.26%
126.83
-42.20%
219.45
End Cash Position
537.70
+191.75%
184.31
+9.04%
169.02
+33.26%
126.83
Free Cash Flow
1,251.96
+16.95%
1,070.50
+11.95%
956.24
+6.22%
900.26
Interest Paid Supplemental Data
260.11
+4.26%
249.47
+32.55%
188.21
+16.10%
162.12
Income Tax Paid Supplemental Data
3.41
-56.58%
7.86
+308.84%
1.92
—
Common Stock Issuance
1.15
+261.51%
0.32
+14.03%
0.28
-99.91%
308.10
Dividend Received CFO
17.12
+42.64%
12.00
+1218.68%
0.91
-3.50%
0.94
Dividends Received CFI
28.50
+24.43%
22.91
+10.98%
20.64
+64.88%
12.52
Earnings Losses From Equity Investments
173.98
+11384.09%
1.51
+114.85%
-10.20
-398.00%
-2.05
Issuance Of Capital Stock
1.15
+261.51%
0.32
+14.03%
0.28
-99.91%
308.10
Net Investment Properties Purchase And Sale
-912.63
-2161.66%
44.27
+107.31%
-605.40
+38.96%
-991.88
Purchase Of Investment Properties
-1,250.36
-106.92%
-604.28
+19.11%
-747.05
+28.15%
-1,039.77
Sale Of Business
0.00
-100.00%
125.66
0.00
-100.00%
125.98
Sale Of Investment Properties
337.72
-47.93%
648.55
+357.85%
141.65
+195.81%
47.88
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category